Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance (Q37945304)

25 August 2017

title

Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance (English)

1 reference

25 August 2017

Tetsuro Sasada

1 reference

25 August 2017

Shigetaka Suekane

series ordinal

1 reference

25 August 2017

publication date

1 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

1235-1251

1 reference

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

The tumor microenvironment and its role in promoting tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumour immunity: effector response to tumour and role of the microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Improving cancer immunotherapy by targeting tumor-induced immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Personalized peptide vaccines: a new therapeutic modality for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Decreased NKG2D expression on CD8+ T cell is involved in immune evasion in patients with gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Inhibition of superoxide generation upon T-cell receptor engagement rescues Mart-1(27-35)-reactive T cells from activation-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

The B7 family and cancer therapy: costimulation and coinhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Modulation of CD103 expression on human colon carcinoma-specific CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

The adaptive immunologic microenvironment in colorectal cancer: a novel perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

FOXP3+ regulatory T cells in the human immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

FOXP3 defines regulatory T cells in human tumor and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

CTLA-4 blockade increases IFNgamma-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

The critical role of type-1 innate and acquired immunity in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

IFN-gamma produced by human papilloma virus-18 E6-specific CD4+ T cells predicts the clinical outcome after surgery in patients with high-grade cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Immunomodulation of breast cancer via tumor antigen specific Th1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Th17 and regulatory T cells in mediating and restraining inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Protumor vs antitumor functions of IL-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

T(H)17 cells in tumour immunity and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumor microenvironments direct the recruitment and expansion of human Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Gammadelta T cells and the lymphoid stress-surveillance response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Regulation of cutaneous malignancy by gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Pitfalls on the roadmap to gammadelta T cell-based cancer immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

CD20+ B cells: the other tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Naturally occurring B-cell responses to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Prognostic impact of lymphocytes in soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: prognostic impact may depend on type of treatment and stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Prospects for the use of NK cells in immunotherapy of human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

21 January 2018

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Clinical applications of natural killer T cell-based immunotherapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Loss of IFN-gamma production by invariant NK T cells in advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Quantum dots brighten biological imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

The dark side of the immunohistochemical moon: industry

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Commercial antibodies: the good, bad, and really ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

FOXP3 immunohistochemistry on formalin-fixed paraffin-embedded tissue: poor correlation between different antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

In situ detection of virus- and tumor-specific T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

T-cell quality in memory and protection: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.106

21 January 2018

Identifiers

DOI

10.2217/IMT.11.106

1 reference

25 August 2017

1 reference